Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic review methodology
PubMed 36739588 · doi:10.1002/gps.5882
What was done
The authors conducted a narrative review to differentiate apathy from depression in individuals with neurocognitive disorders. Literature was retrieved via PubMed searches and supplemented by citation selection based on author experience and knowledge. The synthesis examined clinical presentation, diagnostic criteria, neuropathological characteristics, and treatment responses.
What was found
The abstract reports no quantitative data, effect sizes, or study numbers. Qualitatively, the review found that apathy and depression differ in their underlying neurobiology and their risks of progression to dementia. Apathy is linked to worse clinical outcomes and increased caregiver burden, especially in neurodegenerative conditions such as Alzheimer's disease. There are currently no approved pharmacological therapies for apathy.
Why it matters
Because apathy and depression share overlapping symptoms and often co-occur in neurocognitive disorders, misdiagnosis can lead to inappropriate management. Establishing their distinct neurobiological and clinical profiles helps guide tailored clinical care and underscores the need for targeted therapies for apathy.
Limits
This is a narrative review with non-systematic literature selection, introducing potential selection bias. The abstract provides no quantitative synthesis, sample sizes, or study counts. Distinguishing the two conditions in practice remains inherently difficult due to concurrent presentation and symptom overlap.
Cited by
- supports Apathy and clinical depression are distinct neurobehavioral syndromes that can present in isolation or overlap.